In our cohort, higher CD8+ TILs level in brain tumor had a prolonged OS for either EGFR-mutant LUADs who receiving TKI treatments or patients with lung cancer who not receiving TKI treatments, indicating CD8+ TILs level as a robust prognostic factor. This evidence concerns the gene EGFR and lung carcinoma.